Chicago Federal Reserve President, Austan Goolsbee, expressed confidence that inflation can be controlled without the need for a recession, despite the likelihood of further interest rate increases. Goolsbee believes that the ongoing job growth is a key factor in the Fed’s plan to restore price stability while avoiding any negative impact on the economy. He
The FDA has announced the full approval of Lecanemab (Leqembi) as the first Alzheimer’s treatment that specifically targets the disease process. Teresa Buracchio, MD, acting director of the Office of Neuroscience in the FDA’s Center for Drug Evaluation and Research, describes this development as a significant milestone in the treatment of Alzheimer’s disease. The approval